You are here

Adipose Clinical Trials

Condition:   Critical Limb Ischemia
Intervention:   Other: Mesenchymal stem cells from adipose tissue
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas
Active, not recruiting - verified March 2017
Condition:   Keratopathy
Intervention:   Drug: Expanded adipose-derived stem cells
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Unknown status - verified September 2012
Condition:   Urinary Incontinence
Intervention:   Drug: Adipose-derived expanded stem cells
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Unknown status - verified March 2013
Condition:   Urinary Incontinence
Intervention:   Drug: Inject of Autologous Adipose-derived stem cells
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Completed - verified September 2012
Condition:   Ischemic Stroke
Interventions:   Drug: Allogenic mesenchymal stem cells from adipose tissue;   Drug: Placebo
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Recruiting - verified February 2017
Condition:   Critical Limb Ischemia
Intervention:   Procedure: Autologous Adipose Tissue derived MSCs Transplantation
Sponsors:   Biostar;   Pusan National University Hospital
Completed - verified March 2014
Condition:   Lumbar Intervertebral Disc Degeneration
Intervention:   Procedure: Autologous Adipose Tissue derived MSCs Transplantation
Sponsors:   Biostar;   Korea University Anam Hospital
Unknown status - verified March 2014
Condition:   Avascular Necrosis of the Femoral Head
Intervention:   Procedure: Autologous Adipose Tissue derived MSCs Transplantation
Sponsors:   Biostar;   SMG-SNU Boramae Medical Center
Completed - verified August 2016
Condition:   Spinal Cord Injury
Intervention:   Drug: autologous adipose tissue derived mesenchymal stem cells
Sponsor:   Bukwang Pharmaceutical
Completed - verified June 2012
Conditions:   Perianal Fistula;   Primary; Complex
Interventions:   Biological: Autologous adipose derived stem cells(low dose group);   Biological: Autologous adipose derived stem cells(high dose group)
Sponsor:   Anterogen Co., Ltd.
Terminated - verified June 2012

Pages